Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

Market Cap	8.65B +3.8%
Revenue (ttm)	3.37B +0.3%
Net Income	414.26M -3.4%
EPS	0.91 -2.2%
Shares Out	454.07M
PE Ratio	20.95
Forward PE	17.81
Dividend	0.30 (1.51%)
Ex-Dividend Date	May 21, 2025

Volume	6,039,810
Average Volume	7,713,722
Open	19.97
Previous Close	19.04
Day's Range	18.60 - 19.97
52-Week Range	16.08 - 28.90
Beta	0.35
RSI	39.77
Earnings Date	Mar 31, 2026

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company provides anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poult...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,900
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300119

Financial Performance

In 2024, SHE:300119's revenue was 3.07 billion, an increase of 13.32% compared to the previous year's 2.71 billion. Earnings were 300.72 million, a decrease of -33.70%.